BACKGROUND: Data on treatment satisfaction in European men and women with chronic constipation are limited. AIM: To assess satisfaction with current treatment among European men and women with chronic constipation. METHODS: An internet-based survey was conducted in 2009 in 10 European countries: Austria, Germany, France, Ireland, Italy, Spain, Switzerland, the UK, Belgium and the Netherlands. Participants had self-reported chronic constipation (<3 bowel movements/week and ≥1 symptoms for ≥6 months of: pain during defecation; lumpy/hard faeces; and feeling of incomplete evacuation). Demographic data and disease history were collected. For participants using laxatives, drug name/class, satisfaction with treatment and interest in other treatments were collected. RESULTS: Of the 1941 participants screened, 1355 had chronic constipation and met the inclusion criteria (chronic constipation population). The majority of the chronic constipation population who disclosed their sex (n = 811) were women (82%). Sixty-eight per cent of respondents (n = 855/1255) reported using laxatives, with the proportion of laxative users differing between subsets. Twenty-eight per cent (n = 225/793) were (very) satisfied with their treatment, whereas 44% (n = 345/793) were neutral and 28% (n = 223/793) (very) dissatisfied. There was no relationship between type of laxative and degree of (dis)satisfaction. Interest in other treatments was high with 83% (n = 686/827) of respondents 'absolutely' or 'probably' interested. Respondents dissatisfied with their treatment were more likely to be interested in other treatments. CONCLUSIONS: Laxative-use is common for chronic constipation. In this large survey, 28% of participants were dissatisfied with their treatment, with the majority interested in other treatments.
BACKGROUND: Data on treatment satisfaction in European men and women with chronic constipation are limited. AIM: To assess satisfaction with current treatment among European men and women with chronic constipation. METHODS: An internet-based survey was conducted in 2009 in 10 European countries: Austria, Germany, France, Ireland, Italy, Spain, Switzerland, the UK, Belgium and the Netherlands. Participants had self-reported chronic constipation (<3 bowel movements/week and ≥1 symptoms for ≥6 months of: pain during defecation; lumpy/hard faeces; and feeling of incomplete evacuation). Demographic data and disease history were collected. For participants using laxatives, drug name/class, satisfaction with treatment and interest in other treatments were collected. RESULTS: Of the 1941 participants screened, 1355 had chronic constipation and met the inclusion criteria (chronic constipation population). The majority of the chronic constipation population who disclosed their sex (n = 811) were women (82%). Sixty-eight per cent of respondents (n = 855/1255) reported using laxatives, with the proportion of laxative users differing between subsets. Twenty-eight per cent (n = 225/793) were (very) satisfied with their treatment, whereas 44% (n = 345/793) were neutral and 28% (n = 223/793) (very) dissatisfied. There was no relationship between type of laxative and degree of (dis)satisfaction. Interest in other treatments was high with 83% (n = 686/827) of respondents 'absolutely' or 'probably' interested. Respondents dissatisfied with their treatment were more likely to be interested in other treatments. CONCLUSIONS: Laxative-use is common for chronic constipation. In this large survey, 28% of participants were dissatisfied with their treatment, with the majority interested in other treatments.
Authors: Anton Emmanuel; Eamonn Mm Quigley; Magnus Simrén; Yue Feng; Stefan Müller-Lissner; Daniel Urbain; Jan Tack; Albert J Bredenoord; Jean-Marc Sabaté; Yan Yiannakou; Viola Andresen; Rosario Cuomo; Enrique Rey; Renate Specht Gryp; Lieve Vandeplassche; Dory Solomon Journal: United European Gastroenterol J Date: 2013-10 Impact factor: 4.623
Authors: Yan Yiannakou; Hubert Piessevaux; Michel Bouchoucha; Ingolf Schiefke; Rafal Filip; Libor Gabalec; Ion Dina; David Stephenson; René Kerstens; Kevin Etherson; Amy Levine Journal: Am J Gastroenterol Date: 2015-04-14 Impact factor: 10.864